BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 18368644)

  • 1. The importance of quality-assurance methods for competent execution, handling and structuring of colon cancer screening programs--the case of programs based on stool tests.
    Gibis B
    Z Gastroenterol; 2008 Apr; 46 Suppl 1():S45-6. PubMed ID: 18368644
    [No Abstract]   [Full Text] [Related]  

  • 2. [Colorectal cancer screening: facts and questions].
    Faivre J; Dancourt V
    Gastroenterol Clin Biol; 2002 May; 26(5 Suppl):B86-93. PubMed ID: 12068275
    [No Abstract]   [Full Text] [Related]  

  • 3. [Colorectal cancer screening should be evaluated in Swedish studies].
    Blom J
    Lakartidningen; 2008 Sep 17-23; 105(38):2564-7. PubMed ID: 18846858
    [No Abstract]   [Full Text] [Related]  

  • 4. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition--Evaluation and interpretation of screening outcomes.
    Moss S; Ancelle-Park R; Brenner H;
    Endoscopy; 2012 Sep; 44 Suppl 3():SE49-64. PubMed ID: 23012122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality assurance for screening colonoscopies.
    Birkner B
    Z Gastroenterol; 2008 Apr; 46 Suppl 1():S43-4. PubMed ID: 18368643
    [No Abstract]   [Full Text] [Related]  

  • 6. Stool test for colorectal cancer screening: what is going on?
    Bonanno E; Rulli F; Galatà G; Pucci S; Sesti F; Farinon AM; Spagnoli LG
    Surg Oncol; 2007 Dec; 16 Suppl 1():S43-5. PubMed ID: 18055195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence, efficacy and effectiveness of screening for colorectal cancer with faecal tests.
    Faivre J; Lepage C
    Z Gastroenterol; 2008 Apr; 46 Suppl 1():S17-9. PubMed ID: 18368633
    [No Abstract]   [Full Text] [Related]  

  • 8. Screening for colorectal cancer.
    Brock G; Gurekas V
    CMAJ; 2001 Apr; 164(7):966; author reply 967-8. PubMed ID: 11314445
    [No Abstract]   [Full Text] [Related]  

  • 9. [Feasibility of colorectal cancer screening with fecal occult blood test distributed by public pharmacies].
    Pippa G; Ferrara M; Valle S; Diego B; Alessandra B; Apuzzo M; Bazuro ME; Tammaro G; Federici A
    Recenti Prog Med; 2009; 100(7-8):348-51. PubMed ID: 19725474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition--Communication.
    Austoker J; Giordano L; Hewitson P; Villain P;
    Endoscopy; 2012 Sep; 44 Suppl 3():SE164-85. PubMed ID: 23012120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for colorectal cancer: which test can we afford?
    Lansdorp-Vogelaar I; van Ballegooijen M; Kuipers EJ
    Z Gastroenterol; 2008 Apr; 46 Suppl 1():S38-40. PubMed ID: 18368641
    [No Abstract]   [Full Text] [Related]  

  • 12. Quality indicators for the care of colorectal cancer in vulnerable elders.
    McGory ML
    J Am Geriatr Soc; 2007 Oct; 55 Suppl 2():S277-84. PubMed ID: 17910548
    [No Abstract]   [Full Text] [Related]  

  • 13. Colorectal cancer screening in primary care.
    Lieberman D
    Gastroenterology; 2007 Jun; 132(7):2591-4. PubMed ID: 17570229
    [No Abstract]   [Full Text] [Related]  

  • 14. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population.
    van Rossum LG; van Rijn AF; Laheij RJ; van Oijen MG; Fockens P; van Krieken HH; Verbeek AL; Jansen JB; Dekker E
    Gastroenterology; 2008 Jul; 135(1):82-90. PubMed ID: 18482589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The value of primary health care tests unclear--SBU should evaluate the evidence. Feces-Hb in primary health care illustrates the problem].
    Borgquist L
    Lakartidningen; 2010 May 26-Jun 1; 107(21):1366-7. PubMed ID: 20645609
    [No Abstract]   [Full Text] [Related]  

  • 16. Population-based screening for colorectal cancer: Australian research and implementation.
    Young GP
    J Gastroenterol Hepatol; 2009 Oct; 24 Suppl 3():S33-42. PubMed ID: 19799696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colorectal cancer screening guidelines: the importance of evidence and transparency.
    Allison JE
    Gastroenterology; 2010 May; 138(5):1648-1652.e2. PubMed ID: 20211181
    [No Abstract]   [Full Text] [Related]  

  • 18. Faecal occult blood test-based screening programme with high compliance for colonoscopy has a strong clinical impact on colorectal cancer (Br J Surg 2009; 96: 533-540).
    Nash GF
    Br J Surg; 2009 Aug; 96(8):956-7; author reply 957. PubMed ID: 19591144
    [No Abstract]   [Full Text] [Related]  

  • 19. Cost evaluation in a colorectal cancer screening programme by faecal occult blood test in the District of Florence.
    Grazzini G; Ciatto S; Cislaghi C; Castiglione G; Falcone M; Mantellini P; Zappa M;
    J Med Screen; 2008; 15(4):175-81. PubMed ID: 19106257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colon cancer screening: recommendations and barriers to patient participation.
    Peters DP
    Nurse Pract; 2008 Dec; 33(12):14-20; quiz 21. PubMed ID: 19057341
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.